Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Research|August 9, 2003
Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemiaKathryn Sibley, Sara Rollinson, James M Allan, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Childhood acute lymphoblastic leukaemia and birthweight: insights from a pooled analysis of case-control data from Germany, the United Kingdom and the United StatesEve Roman, Tracy Lightfoot, Alexandra G Smith, et al.
Blood|September 2, 2004
Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapyJames M Allan, Alexandra G Smith, Keith Wheatley, et al.
Autophagy|January 18, 2021
BNIP3-dependent mitophagy promotes cytosolic localization of LC3B and metabolic homeostasis in the liverMaya Z Springer, Logan P Poole, Lauren E Drake, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2004
High-throughput association testing on DNA pools to identify genetic variants that confer susceptibility to acute myeloid leukemiaSara Rollinson, James M Allan, Graham R Law, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agentsLisa J Worrillow, Lois B Travis, Alexandra G Smith, et al.
Blood|March 19, 2020
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network reportStuart E Lacy, Sharon L Barrans, Philip A Beer, et al.
Cancer Causes & Control : CCC|June 6, 2019
Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysisJames R Cerhan, Eleanor Kane, Claire M Vajdic, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectMartha S Linet, Claire M Vajdic, Lindsay M Morton, et al.
Blood Advances|July 11, 2022
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IVG Tjitske Los-de Vries, Wendy B C Stevens, Erik van Dijk, et al.
Pageof 4